| Product dosage: 150mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.37 | $41.06 (0%) | 🛒 Add to cart |
| 60 | $1.07 | $82.12 $64.10 (22%) | 🛒 Add to cart |
| 90 | $0.97 | $123.18 $87.13 (29%) | 🛒 Add to cart |
| 120 | $0.93 | $164.24 $111.17 (32%) | 🛒 Add to cart |
| 180 | $0.87 | $246.37 $157.23 (36%) | 🛒 Add to cart |
| 270 | $0.84 | $369.55 $227.34 (38%) | 🛒 Add to cart |
| 360 | $0.83
Best per pill | $492.73 $297.44 (40%) | 🛒 Add to cart |
Similar products
More info:
Bupropion: Effective Depression and Smoking Cessation Treatment - Evidence-Based Review
Bupropion is an atypical antidepressant belonging to the aminoketone class, structurally distinct from SSRIs and TCAs. Initially developed in 1969 and approved by the FDA in 1985, it functions primarily as a norepinephrine-dopamine reuptake inhibitor (NDRI) with minimal serotonergic activity. This unique mechanism underlies its clinical applications beyond depression, including smoking cessation and off-label uses for ADHD and sexual dysfunction. Unlike many antidepressants, bupropion is associated with weight neutrality or modest weight loss and lacks sexual side effects, making it particularly valuable for specific patient populations.
Antabuse: Aversive Deterrent Therapy for Alcohol Use Disorder - Evidence-Based Review
Disulfiram, marketed under the brand name Antabuse, represents one of the oldest pharmacological interventions for chronic alcohol use disorder. It’s not a cure for alcoholism but rather an aversive therapy that creates significant physical discomfort when alcohol is consumed, acting as a psychological deterrent. The drug works by irreversibly inhibiting aldehyde dehydrogenase (ALDH), causing acetaldehyde accumulation—the compound responsible for hangover symptoms—leading to a highly unpleasant reaction when even small amounts of alcohol are ingested.
asendin
Let me walk you through our experience with Asendin - the amoxapine formulation that’s been quietly revolutionizing how we approach certain depression subtypes. When it first hit our formulary back in 2018, honestly, most of us were skeptical. Another tricyclic derivative? Really? But Dr. Chen in psych kept pushing us to look at the receptor profile differently. ## What is Asendin? Its Role in Modern Medicine Asendin (amoxapine) represents what happens when you take the classic tricyclic antidepressant structure and actually optimize it for modern practice.
Bupron SR: Sustained Mood Stabilization and Smoking Cessation Support - Evidence-Based Review
Bupron SR is a sustained-release formulation of bupropion hydrochloride, primarily indicated for the management of major depressive disorder and as an aid to smoking cessation treatment. Unlike immediate-release formulations, this extended-release delivery system maintains stable plasma concentrations over 24 hours, potentially improving tolerability while maintaining therapeutic efficacy. The SR designation indicates this specialized release profile, which represents a significant advancement in antidepressant delivery systems. 1. Introduction: What is Bupron SR? Its Role in Modern Medicine When we talk about Bupron SR in clinical practice, we’re discussing a second-generation antidepressant that’s carved out a unique niche since its development in the late 1980s.
Buspar: Effective Anxiety Management Without Sedation or Dependence - Evidence-Based Review
Buspirone hydrochloride, marketed under the brand name Buspar, represents one of the more interesting anxiolytics in our psychiatric toolkit - it’s neither a benzodiazepine nor an SSRI, but occupies this unique pharmacological space that continues to reveal new dimensions even decades after its introduction. What we’re dealing with here is an azapirone compound that functions primarily as a partial agonist at serotonin 5-HT1A receptors, though as I’ll explain, that’s just the beginning of the story.
champix
Let me walk you through our experience with Champix – not the polished marketing version, but what actually happens in clinical practice. When Pfizer first introduced varenicline to our formulary committee back in 2007, we were skeptical. Another smoking cessation aid? Really? The mechanism seemed almost too elegant – partial nicotine receptor agonist that would both reduce withdrawal symptoms and block the pleasure of smoking if you did slip up. Our pulmonology department lead, Dr.
contrave
Contrave represents one of the more interesting pharmacological approaches to weight management I’ve encountered in my 20 years of obesity medicine practice. It’s not another “magic pill” but rather a rational combination of two established medications that work through complementary pathways. What struck me initially was how the combination addresses both the physiological and behavioral aspects of weight regulation - something most single-agent therapies miss completely. Contrave: Effective Weight Management Through Dual Mechanism Action - Evidence-Based Review 1.
Effexor XR: Dual-Action Relief for Treatment-Resistant Depression - Evidence-Based Review
Effexor XR is an extended-release formulation of venlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI) primarily prescribed for major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder. Its unique dual mechanism distinguishes it from selective serotonin reuptake inhibitors (SSRIs), offering an alternative for patients with inadequate response to first-line treatments. The extended-release delivery system provides stable plasma concentrations with once-daily dosing, improving adherence and reducing peak-dose side effects. 1. Introduction: What is Effexor XR?
enclomisign
Enclomisign represents one of the more fascinating developments in male reproductive endocrinology we’ve seen in the last decade. It’s not your typical testosterone replacement therapy—rather than adding exogenous hormones, it works by stimulating the body’s own testosterone production through selective estrogen receptor modulation. The compound started showing up in compounding pharmacies around 2015, and we’ve been tracking its effects in our clinic since 2017. What’s interesting is how it evolved from research on enclomiphene citrate, the trans-isomer of clomiphene, with better receptor specificity and fewer side effects.